Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33
Despite their demonstrated potential in preclinical and clinical studies, challenges persist with these agents
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
FDA Approvals and Clinical Trials Currently, GLP-1s are not FDA-approved for any addiction treatment
Here we explore how this vitamin can impact weight
The telehealth startup Ro, for example, offered an introductory month of tirzepatide for weight loss for $99